Drug-Eluting Stents for Saphenous Vein Graft Lesions The Limits of Evidence

被引：4
作者：
Bittl, John A. [1 ]
机构：
[1] Munroe Reg Med Ctr, Ocala Heart Inst, Ocala, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 11期
关键词：
atherosclerosis; randomized trials; restenosis; CORONARY-ARTERY DISEASE; CLINICAL FOLLOW-UP; BARE-METAL STENT; BALLOON ANGIOPLASTY; BYPASS GRAFTS; IMPLANTATION; PLACEMENT;
D O I：
10.1016/j.jacc.2008.12.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：929 / 930
页数：2
相关论文
共 15 条
  • [1] Should Bare Metal or Drug-Eluting Stents Be Used During PCI of Saphenous Vein Graft Lesions: Waiting For Godot?
    Brilakis, Emmanouil S.
    Berger, Peter B.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 72 (06) : 815 - 818
  • [2] A Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions The SOS (Stenting Of Saphenous Vein Grafts) Trial
    Brilakis, Emmanouil S.
    Lichtenwalter, Christopher
    de Lemos, James A.
    Roesle, Michele
    Obel, Owen
    Haagen, Donald
    Saeed, Bilal
    Gadiparthi, Chiranjeevi
    Bissett, Joseph K.
    Sachdeva, Rajesh
    Voudris, Vassilios V.
    Karyofillis, Panagiotis
    Kar, Biswajit
    Rossen, James
    Fasseas, Panayotis
    Berger, Peter
    Banerjee, Subhash
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (11) : 919 - 928
  • [3] Brodie BR, 2008, JACC-CARDIOVASC INTE, V1, P405, DOI 10.1016/j.jcin.2008.06.005
  • [4] Late myocardial ischemic events after saphenous vein graft intervention - Importance of initially ''nonsignificant'' vein graft lesions
    Ellis, SG
    Brener, SJ
    DeLuca, S
    Tuzcu, EM
    Raymond, RE
    Whitlow, PL
    Topol, EJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (11) : 1460 - 1464
  • [5] A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE
    FISCHMAN, DL
    LEON, MB
    BAIM, DS
    SCHATZ, RA
    SAVAGE, MP
    PENN, I
    DETRE, K
    VELTRI, L
    RICCI, D
    NOBUYOSHI, M
    CLEMAN, M
    HEUSER, R
    ALMOND, D
    TEIRSTEIN, PS
    FISH, RD
    COLOMBO, A
    BRINKER, J
    MOSES, J
    SHAKNOVICH, A
    HIRSHFELD, J
    BAILEY, S
    ELLIS, S
    RAKE, R
    GOLDBERG, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) : 496 - 501
  • [6] Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts
    Gioia, Giuseppe
    Benassi, Facc Alberto
    Mohendra, Raghar
    Chowdhury, Khaza
    Masood, Iqbal
    Matthai, William
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 72 (01) : 13 - 20
  • [7] Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels
    Hoffmann, Rainer
    Hamm, Christian
    Nienaber, Christoph A.
    Levenson, Benny
    Bonzel, Tassilo
    Sabin, Georg
    Senges, Jochen
    Zahn, Ralf
    Tebbe, Ulrich
    Pfannebecker, Thomas
    Richardt, Hans Gert
    Schneider, Steffen
    Kelm, Malte
    [J]. CORONARY ARTERY DISEASE, 2007, 18 (07) : 559 - 564
  • [8] KOLATA G, 2008, NY TIMES, V158, pD1
  • [9] RATLIFF NB, 1989, ARCH PATHOL LAB MED, V113, P772
  • [10] Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts
    Ribichin, Flavio
    Pugno, Francesco
    Ferrero, Valeria
    Wijns, William
    Vacca, Giovanni
    Vassanelli, Corrado
    Virmani, Renu
    [J]. CLINICAL SCIENCE, 2008, 114 (3-4) : 211 - 220
12